Frank Massam
Founder and Chief Executive Officer
Nemesis Bioscience
United Kingdom
Biography
Frank joined the company as CEO in July 2014. Before this he was Chief Operating Officer at Population Genetics Technologies with responsibility for the company’s commercial strategy and operations, including inward investment and out-licensing agreements with major life science organisations. He was previously Senior Director of Strategic Planning and New Business Development at Agilent Technologies, President of Pharmagene, Inc. and Senior Director of Business Development at Incyte Genomics in California. At Incyte he led a team that out-licensed the company’s sequence and expression databases to senior executives at 28 of the world’s top 30 pharmaceutical companies. Before this he was the President of AMS Neve, Inc., a Siemens company in the USA. He also founded and managed The Idbury Group, a life-science focused strategic marketing consultancy. Originally trained as a microbiologist in the UK’s Public Health Laboratory Service, he holds a PhD in Clinical Microbiology.
Research Interest
Frank has research interest in Business Management.
